指责
发表于 2025-3-21 16:23:09
书目名称HMG-CoA Reductase Inhibitors影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0420250<br><br> <br><br>书目名称HMG-CoA Reductase Inhibitors影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0420250<br><br> <br><br>书目名称HMG-CoA Reductase Inhibitors网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0420250<br><br> <br><br>书目名称HMG-CoA Reductase Inhibitors网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0420250<br><br> <br><br>书目名称HMG-CoA Reductase Inhibitors被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0420250<br><br> <br><br>书目名称HMG-CoA Reductase Inhibitors被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0420250<br><br> <br><br>书目名称HMG-CoA Reductase Inhibitors年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0420250<br><br> <br><br>书目名称HMG-CoA Reductase Inhibitors年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0420250<br><br> <br><br>书目名称HMG-CoA Reductase Inhibitors读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0420250<br><br> <br><br>书目名称HMG-CoA Reductase Inhibitors读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0420250<br><br> <br><br>
fallible
发表于 2025-3-21 23:57:19
http://reply.papertrans.cn/43/4203/420250/420250_2.png
好开玩笑
发表于 2025-3-22 03:28:43
http://reply.papertrans.cn/43/4203/420250/420250_3.png
MIME
发表于 2025-3-22 06:06:33
http://reply.papertrans.cn/43/4203/420250/420250_4.png
anus928
发表于 2025-3-22 11:10:57
http://reply.papertrans.cn/43/4203/420250/420250_5.png
空气
发表于 2025-3-22 13:58:31
The Hatfield Photographic Lunar Atlasarction or stroke is of particular relevance, because, in addition to the considerable impairment to health, it creates immense economic demands. Atherosclerosis plays a central role as an etiological component in the development of this disease. The scientific data published in the past decade are
HACK
发表于 2025-3-22 20:30:06
http://reply.papertrans.cn/43/4203/420250/420250_7.png
PAN
发表于 2025-3-22 21:16:39
https://doi.org/10.1007/978-1-4614-8639-8e substantial. Consequently, both the primary and secondary prevention of CHD are major objectives of healthcare systems worldwide. Recently, large, multi-centre, clinical trials have demonstrated consistently that these objectives can be achieved though cholesterol-lowering therapy with 3-hydroxy-3
交响乐
发表于 2025-3-23 01:53:41
http://reply.papertrans.cn/43/4203/420250/420250_9.png
衍生
发表于 2025-3-23 07:57:08
Structure and mechanisms of action of HMG-CoA reductase inhibitors,ich remains the leading cause of death in our society [.]. The efficacy of LDL reduction in the prevention of CHD has clearly been demonstrated in a number of primary and secondary intervention trials (reviewed in reference [.]). Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductas